We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2319:HKEXChina Mengniu Dairy Company Limited Analysis

Data as of 2026-03-11 - not real-time

HK$16.03

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

China Mengniu Dairy (2319.HK) is trading at HK$16.03, comfortably above its 20‑day SMA of 16.31 and the 50‑day SMA of 15.96, signalling a short‑term bullish bias. The stock sits midway between a clear support zone near HK$14.83 and resistance around HK$17.88, giving it room to test the upside while the increasing volume supports the move. However, the MACD line remains below its signal line, producing a bearish histogram that warns of possible short‑term weakness. Volatility is elevated at roughly 30% over the past 30 days, yet beta is very low (0.10), indicating the price swings are largely company‑specific rather than market‑driven. Fundamentals show a negative trailing EPS but a healthy forward EPS of 1.47 HKD, yielding a forward P/E near 11, and a dividend yield of 3.44% with a modest payout ratio of 18.5%. Analysts are overwhelmingly positive, with a “strong buy” consensus and median target price of HK$20.87, implying roughly 30% upside. Overall sentiment is buoyant, reflected by an “Extreme Greed” reading on the fear‑greed index.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD divergence suggests caution
  • Increasing volume supports current price level
  • Attractive dividend yield provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward earnings forecast and reasonable forward P/E
  • Analyst target price indicates ~30% upside
  • Stable cash position and sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Defensive consumer sector with long‑term demand for dairy
  • Consistent dividend policy and low beta
  • Potential earnings turnaround as profit margin improves

Key Metrics & Analysis

Financial Health

Revenue Growth-6.90%
Profit Margin-0.35%
P/E Ratio10.9
ROE-0.31%
ROA3.77%
Debt/Equity61.90
P/B Ratio1.3
Op. Cash FlowHK$9.2B
Free Cash FlowHK$1.2B

Technical Analysis

TrendBullish
RSI49.2
SupportHK$14.83
ResistanceHK$17.88
MA 20HK$16.31
MA 50HK$15.96
MA 200HK$15.78
MACDBearish
VolumeIncreasing
Fear & Greed Index76.5

Valuation

Fair ValueHK$1.93
Target PriceHK$21.17
Upside/Downside32.09%
GradeFair
TypeBlend
Dividend Yield3.44%

Risk Assessment

Beta0.10
Volatility39.36%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.